Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FL029
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,537
Award facts
- Contract value 100% obligated
- $53,537.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $53.5K delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pens on January 23, 2026, with completion scheduled for January 26, 2026. This is a firm fixed-price, non-set-aside award utilizing a competitive procurement process. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1 billion through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, operates as a critical pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The supply of Zepbound, a prescription diabetes medication, aligns with the company's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains under the DLA Medical Supply Chain. The firm fixed-price structure and rapid completion timeline reflect the efficient fulfillment capabilities the contractor has demonstrated through numerous prior delivery orders ranging from minimal to substantial values across the federal healthcare procurement landscape.
Quick answers
Who was awarded contract SPE2DR26FL029?
SPE2DR26FL029 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FL029 worth?
The government has obligated $53,537 on SPE2DR26FL029.
Is contract SPE2DR26FL029 an order under another contract?
Yes. SPE2DR26FL029 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL029 competed?
The extent of competition for SPE2DR26FL029 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award